KC, W., & AM, M. (2017). Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: A short review of the clinical evidence. Therapeutics and clinical risk management, 13, 447. https://doi.org/10.2147/TCRM.S88911
Chicago Style (17th ed.) CitationKC, Willett, and Morrill AM. "Use of Direct Oral Anticoagulants for the Prevention and Treatment of Thromboembolic Disease in Patients with Reduced Renal Function: A Short Review of the Clinical Evidence." Therapeutics and Clinical Risk Management 13 (2017): 447. https://doi.org/10.2147/TCRM.S88911.
MLA (9th ed.) CitationKC, Willett, and Morrill AM. "Use of Direct Oral Anticoagulants for the Prevention and Treatment of Thromboembolic Disease in Patients with Reduced Renal Function: A Short Review of the Clinical Evidence." Therapeutics and Clinical Risk Management, vol. 13, 2017, p. 447, https://doi.org/10.2147/TCRM.S88911.
